Application 209312
- Type
- ANDA
- Sponsor
- GRANULES INDIA LTD
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | METHOCARBAMOL | METHOCARBAMOL | TABLET;ORAL | 500MG | No | Yes |
| 002 | METHOCARBAMOL | METHOCARBAMOL | TABLET;ORAL | 750MG | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A209312-001 | METHOCARBAMOL | METHOCARBAMOL | 500MG | TABLET / ORAL | AA | RS | 2018-05-07 |
| A209312-002 | METHOCARBAMOL | METHOCARBAMOL | 750MG | TABLET / ORAL | AA | RS | 2018-05-07 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A209312-001 | AA |
| A209312-002 | AA |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | A209312-001 | METHOCARBAMOL | 500MG | TABLET / ORAL | AA | RS | 2018-05-07 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | A209312-002 | METHOCARBAMOL | 750MG | TABLET / ORAL | AA | RS | 2018-05-07 | 84e616aacf4f… |
| 2026-08-18 06:07:40 | 2026-07 | A209312-001 | METHOCARBAMOL | 500MG | TABLET / ORAL | AA | RS | 2018-05-07 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | A209312-002 | METHOCARBAMOL | 750MG | TABLET / ORAL | AA | RS | 2018-05-07 | caaa826d4ba7… |
| 2026-02-19 14:30 UTC | 2026-02 | A209312-001 | METHOCARBAMOL | 500MG | TABLET / ORAL | AA | RS | 2018-05-07 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A209312-002 | METHOCARBAMOL | 750MG | TABLET / ORAL | AA | RS | 2018-05-07 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A209312-001 | METHOCARBAMOL | 500MG | TABLET / ORAL | AA | RS | 2018-05-07 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A209312-002 | METHOCARBAMOL | 750MG | TABLET / ORAL | AA | RS | 2018-05-07 | 31067a03dcf5… |
| 2025-08-23 18:47 UTC | 2025-08 | A209312-001 | METHOCARBAMOL | 500MG | TABLET / ORAL | AA | RS | 2018-05-07 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | A209312-002 | METHOCARBAMOL | 750MG | TABLET / ORAL | AA | RS | 2018-05-07 | 6a471c1ec25d… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A209312-001 | METHOCARBAMOL | 500MG | TABLET / ORAL | AA | RS | 2018-05-07 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A209312-002 | METHOCARBAMOL | 750MG | TABLET / ORAL | AA | RS | 2018-05-07 | fd3edfee7708… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A209312-001 | METHOCARBAMOL | 500MG | TABLET / ORAL | AA | RS | 2018-05-07 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A209312-002 | METHOCARBAMOL | 750MG | TABLET / ORAL | AA | RS | 2018-05-07 | b8a1b40f171c… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A209312-001 | METHOCARBAMOL | 500MG | TABLET / ORAL | AA | RS | 2018-05-07 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A209312-002 | METHOCARBAMOL | 750MG | TABLET / ORAL | AA | RS | 2018-05-07 | 03ed91905a0d… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A209312-001 | METHOCARBAMOL | 500MG | TABLET / ORAL | AA | RS | 2018-05-07 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A209312-002 | METHOCARBAMOL | 750MG | TABLET / ORAL | AA | RS | 2018-05-07 | 2680178bc6a6… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A209312-001 | METHOCARBAMOL | 500MG | TABLET / ORAL | AA | RS | 2018-05-07 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A209312-002 | METHOCARBAMOL | 750MG | TABLET / ORAL | AA | RS | 2018-05-07 | 5bbf6a4d5a75… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A209312-001 | METHOCARBAMOL | 500MG | TABLET / ORAL | AA | RS | 2018-05-07 | d8e5a09893c0… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A209312-002 | METHOCARBAMOL | 750MG | TABLET / ORAL | AA | RS | 2018-05-07 | d8e5a09893c0… |
| 2024-10-29 15:01 UTC | 2024-10 | A209312-001 | METHOCARBAMOL | 500MG | TABLET / ORAL | AA | RS | 2018-05-07 | d06236e962d9… |
| 2024-10-29 15:01 UTC | 2024-10 | A209312-002 | METHOCARBAMOL | 750MG | TABLET / ORAL | AA | RS | 2018-05-07 | d06236e962d9… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A209312-001 | METHOCARBAMOL | 500MG | TABLET / ORAL | AA | RS | 2018-05-07 | 79d66fd596c7… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A209312-002 | METHOCARBAMOL | 750MG | TABLET / ORAL | AA | RS | 2018-05-07 | 79d66fd596c7… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A209312-001 | METHOCARBAMOL | 500MG | TABLET / ORAL | AA | RS | 2018-05-07 | 301d65b070ca… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A209312-002 | METHOCARBAMOL | 750MG | TABLET / ORAL | AA | RS | 2018-05-07 | 301d65b070ca… |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A209312-001 | METHOCARBAMOL | 500MG | TABLET / ORAL | AA | RS | 2018-05-07 | 1e350fbaab3a… |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A209312-002 | METHOCARBAMOL | 750MG | TABLET / ORAL | AA | RS | 2018-05-07 | 1e350fbaab3a… |
| 2024-05-31 18:47 UTC | 2024-05 | A209312-001 | METHOCARBAMOL | 500MG | TABLET / ORAL | AA | RS | 2018-05-07 | 8072bd15b7f6… |
| 2024-05-31 18:47 UTC | 2024-05 | A209312-002 | METHOCARBAMOL | 750MG | TABLET / ORAL | AA | RS | 2018-05-07 | 8072bd15b7f6… |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A209312-001 | METHOCARBAMOL | 500MG | TABLET / ORAL | AA | RS | 2018-05-07 | 5c6f7cd8ea54… |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A209312-002 | METHOCARBAMOL | 750MG | TABLET / ORAL | AA | RS | 2018-05-07 | 5c6f7cd8ea54… |
| 2022-04-08 23:34 UTC | 2022-04 | A209312-001 | METHOCARBAMOL | 500MG | TABLET / ORAL | AA | RS | 2018-05-07 | 5d02ea3f76ae… |
| 2022-04-08 23:34 UTC | 2022-04 | A209312-002 | METHOCARBAMOL | 750MG | TABLET / ORAL | AA | RS | 2018-05-07 | 5d02ea3f76ae… |
| 2022-04-04 05:41 UTC | 2022-04 | A209312-001 | METHOCARBAMOL | 500MG | TABLET / ORAL | AA | RS | 2018-05-07 | 4b0b4de00fa7… |
| 2022-04-04 05:41 UTC | 2022-04 | A209312-002 | METHOCARBAMOL | 750MG | TABLET / ORAL | AA | RS | 2018-05-07 | 4b0b4de00fa7… |
| 2019-12-13 00:20 UTC | 2019-12 | A209312-001 | METHOCARBAMOL | 500MG | TABLET / ORAL | AA | RS | 2018-05-07 | 74a2ff9319b5… |
| 2019-12-13 00:20 UTC | 2019-12 | A209312-002 | METHOCARBAMOL | 750MG | TABLET / ORAL | AA | 2018-05-07 | 74a2ff9319b5… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | A209312-001 | AA | 1 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | A209312-002 | AA | 1 | 84e616aacf4f… |
| 2026-08-18 06:07:40 | 2026-07 | A209312-001 | AA | 1 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | A209312-002 | AA | 1 | caaa826d4ba7… |
| 2026-02-19 14:30 UTC | 2026-02 | A209312-001 | AA | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A209312-002 | AA | 1 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A209312-001 | AA | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A209312-002 | AA | 1 | 31067a03dcf5… |
| 2025-08-23 18:47 UTC | 2025-08 | A209312-001 | AA | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | A209312-002 | AA | 1 | 6a471c1ec25d… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A209312-001 | AA | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A209312-002 | AA | 1 | fd3edfee7708… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A209312-001 | AA | 1 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A209312-002 | AA | 1 | b8a1b40f171c… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A209312-001 | AA | 1 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A209312-002 | AA | 1 | 03ed91905a0d… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A209312-001 | AA | 1 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A209312-002 | AA | 1 | 2680178bc6a6… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A209312-001 | AA | 1 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A209312-002 | AA | 1 | 5bbf6a4d5a75… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A209312-001 | AA | 1 | d8e5a09893c0… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A209312-002 | AA | 1 | d8e5a09893c0… |
| 2024-10-29 15:01 UTC | 2024-10 | A209312-001 | AA | 1 | d06236e962d9… |
| 2024-10-29 15:01 UTC | 2024-10 | A209312-002 | AA | 1 | d06236e962d9… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A209312-001 | AA | 1 | 79d66fd596c7… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A209312-002 | AA | 1 | 79d66fd596c7… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A209312-001 | AA | 1 | 301d65b070ca… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A209312-002 | AA | 1 | 301d65b070ca… |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A209312-001 | AA | 1 | 1e350fbaab3a… |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A209312-002 | AA | 1 | 1e350fbaab3a… |
| 2024-05-31 18:47 UTC | 2024-05 | A209312-001 | AA | 1 | 8072bd15b7f6… |
| 2024-05-31 18:47 UTC | 2024-05 | A209312-002 | AA | 1 | 8072bd15b7f6… |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A209312-001 | AA | 1 | 5c6f7cd8ea54… |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A209312-002 | AA | 1 | 5c6f7cd8ea54… |
| 2022-04-08 23:34 UTC | 2022-04 | A209312-001 | AA | 1 | 5d02ea3f76ae… |
| 2022-04-08 23:34 UTC | 2022-04 | A209312-002 | AA | 1 | 5d02ea3f76ae… |
| 2022-04-04 05:41 UTC | 2022-04 | A209312-001 | AA | 1 | 4b0b4de00fa7… |
| 2022-04-04 05:41 UTC | 2022-04 | A209312-002 | AA | 1 | 4b0b4de00fa7… |
| 2019-12-13 00:20 UTC | 2019-12 | A209312-001 | AA | 1 | 74a2ff9319b5… |
| 2019-12-13 00:20 UTC | 2019-12 | A209312-002 | AA | 1 | 74a2ff9319b5… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Methocarbamol | METHOCARBAMOL TABLETS | Northwind Health Company, LLC | f2b4ed5f-3489-9ee4-e053-2995a90a25f0 | 2026-01-01 | Warnings, Adverse reactions | 209312 ANDA209312 |
| Methocarbamol | METHOCARBAMOL TABLETS | Redpharm Drug | 46e983de-434e-7ff3-e063-6394a90aa466 | 2025-12-27 | Warnings, Adverse reactions | 209312 ANDA209312 |
| Methocarbamol | METHOCARBAMOL TABLETS | Granules India Ltd | 42c0a177-7d62-4bcf-9fce-7dd484cda4d5 | 2025-12-01 | Warnings, Adverse reactions | 209312 ANDA209312 62207-770 62207-754 |
| Methocarbamol | METHOCARBAMOL TABLETS | PHOENIX RX LLC | 414b2fe0-fa2b-2b18-e063-6394a90ab2b9 | 2025-10-16 | Warnings, Adverse reactions | 209312 ANDA209312 |
| Methocarbamol | METHOCARBAMOL TABLETS | A-S Medication Solutions | f07c0a35-fb5d-43a1-a33e-d6a51a5fcd77 | 2025-07-23 | Warnings, Adverse reactions | 209312 ANDA209312 50090-3570 |
| Methocarbamol | METHOCARBAMOL TABLETS | A-S Medication Solutions | 5f746f0f-e884-46d9-a104-529293b0fb90 | 2025-07-23 | Warnings, Adverse reactions | 209312 ANDA209312 50090-3557 |
| Methocarbamol | METHOCARBAMOL TABLETS | A-S Medication Solutions | fe872a3a-fb14-4a0a-b9e4-c9f1885b4978 | 2025-06-18 | Warnings, Adverse reactions | 209312 ANDA209312 |
| Methocarbamol | METHOCARBAMOL TABLETS | A-S Medication Solutions | 2a99a422-6bad-4316-90bc-e7c2d1e3fb53 | 2025-04-08 | Warnings, Adverse reactions | 209312 ANDA209312 50090-3556 |
| Methocarbamol | METHOCARBAMOL TABLETS | Asclemed USA, Inc. | edbcf8c6-0df8-4e72-885b-16d378f06c7b | 2025-01-28 | Warnings, Adverse reactions | 209312 ANDA209312 |
| Methocarbamol | METHOCARBAMOL | Advanced Rx of Tennessee, LLC | af73ae4b-bcf5-2e21-e053-2a95a90a2dce | 2024-12-31 | Warnings, Adverse reactions | 209312 ANDA209312 |
| Methocarbamol | METHOCARBAMOL TABLETS | Pharmasource Meds, LLC | f43a9389-c641-ce49-e053-2a95a90a537f | 2024-05-28 | Warnings, Adverse reactions | 209312 ANDA209312 |
| Methocarbamol | METHOCARBAMOL TABLETS | Proficient Rx LP | f6193255-0e83-4510-bc86-30c926ee8fd1 | 2022-04-01 | Warnings, Adverse reactions | 209312 ANDA209312 |
| Methocarbamol | METHOCARBAMOL TABLETS | Aphena Pharma Solutions - Tennessee, LLC | 3757cd8e-6054-4b75-bb04-d11f34c65cbe | 2018-09-12 | Warnings, Adverse reactions | 209312 ANDA209312 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 35573-413 | Methocarbamol | Methocarbamol | Burel Pharmaceuticals, Inc. | ANDA | Current |
| 35573-413 | Methocarbamol | Methocarbamol | Burel Pharmaceuticals, Inc. | ANDA | Current |
| 35573-413 | Methocarbamol | Methocarbamol | Burel Pharmaceuticals, Inc. | ANDA | Current |
| 35573-413 | Methocarbamol | Methocarbamol | Burel Pharmaceuticals, Inc. | ANDA | Current |
| 35573-414 | Methocarbamol | Methocarbamol | Burel Pharmaceuticals, Inc. | ANDA | Current |
| 35573-414 | Methocarbamol | Methocarbamol | Burel Pharmaceuticals, Inc. | ANDA | Current |
| 35573-414 | Methocarbamol | Methocarbamol | Burel Pharmaceuticals, Inc. | ANDA | Current |
| 35573-414 | Methocarbamol | Methocarbamol | Burel Pharmaceuticals, Inc. | ANDA | Current |
| 43063-903 | Methocarbamol | Methocarbamol Tablets | PD-Rx Pharmaceuticals, In | ANDA | Current |
| 43063-903 | Methocarbamol | Methocarbamol Tablets | PD-Rx Pharmaceuticals, Inc. | ANDA | Current |
| 43063-903 | Methocarbamol | Methocarbamol Tablets | PD-Rx Pharmaceuticals, Inc. | ANDA | Current |
| 43063-903 | Methocarbamol | Methocarbamol Tablets | PD-Rx Pharmaceuticals, Inc. | ANDA | Current |
| 43063-903 | Methocarbamol | Methocarbamol Tablets | PD-Rx Pharmaceuticals, Inc. | ANDA | Current |
| 43063-903 | Methocarbamol | Methocarbamol Tablets | PD-Rx Pharmaceuticals, Inc. | ANDA | Current |
| 43063-903 | Methocarbamol | Methocarbamol Tablets | PD-Rx Pharmaceuticals, Inc. | ANDA | Current |
| 43063-905 | Methocarbamol | Methocarbamol Tablets | PD-Rx Pharmaceuticals, In | ANDA | Current |
| 43063-905 | Methocarbamol | Methocarbamol Tablets | PD-Rx Pharmaceuticals, Inc. | ANDA | Current |
| 43063-905 | Methocarbamol | Methocarbamol Tablets | PD-Rx Pharmaceuticals, Inc. | ANDA | Current |
| 43063-905 | Methocarbamol | Methocarbamol Tablets | PD-Rx Pharmaceuticals, Inc. | ANDA | Current |
| 43063-905 | Methocarbamol | Methocarbamol Tablets | PD-Rx Pharmaceuticals, Inc. | ANDA | Current |
| 43063-905 | Methocarbamol | Methocarbamol Tablets | PD-Rx Pharmaceuticals, Inc. | ANDA | Current |
| 50090-3556 | Methocarbamol | Methocarbamol Tablets | A-S Medication Solutions | ANDA | Current |
| 50090-3556 | Methocarbamol | Methocarbamol Tablets | A-S Medication Solutions | ANDA | Current |
| 50090-3556 | Methocarbamol | Methocarbamol Tablets | A-S Medication Solutions | ANDA | Current |
| 50090-3557 | Methocarbamol | Methocarbamol Tablets | A-S Medication Solutions | ANDA | Current |
| 50090-3557 | Methocarbamol | Methocarbamol Tablets | A-S Medication Solutions | ANDA | Current |
| 50090-3557 | Methocarbamol | Methocarbamol Tablets | A-S Medication Solutions | ANDA | Current |
| 50090-3570 | Methocarbamol | Methocarbamol Tablets | A-S Medication Solutions | ANDA | Current |
| 50090-3570 | Methocarbamol | Methocarbamol Tablets | A-S Medication Solutions | ANDA | Current |
| 50090-3570 | Methocarbamol | Methocarbamol Tablets | A-S Medication Solutions | ANDA | Current |
| 50436-0770 | Methocarbamol | Methocarbamol Tablets | Unit Dose Services | ANDA | Current |
| 53002-3591 | Methocarbamol | Methocarbamol Tablets | RPK Pharmaceuticals, Inc. | ANDA | Current |
| 60760-770 | Methocarbamol | Methocarbamol Tablets | St. Mary's Medical Park Pharmacy | ANDA | Current |
| 60760-770 | Methocarbamol | Methocarbamol Tablets | St. Mary's Medical Park Pharmacy | ANDA | Current |
| 60760-770 | Methocarbamol | Methocarbamol Tablets | St. Mary's Medical Park Pharmacy | ANDA | Current |
| 61919-610 | Methocarbamol | Methocarbamol | DirectRX | ANDA | Current |
| 61919-610 | Methocarbamol | Methocarbamol | DirectRX | ANDA | Current |
| 61919-610 | Methocarbamol | Methocarbamol | Direct_Rx | ANDA | Current |
| 61919-610 | Methocarbamol | Methocarbamol | Direct_Rx | ANDA | Current |
| 61919-610 | Methocarbamol | Methocarbamol | Direct_Rx | ANDA | Current |
| 61919-610 | Methocarbamol | Methocarbamol | Direct_Rx | ANDA | Current |
| 61919-610 | Methocarbamol | Methocarbamol | Direct_Rx | ANDA | Current |
| 61919-610 | Methocarbamol | Methocarbamol | Direct_Rx | ANDA | Current |
| 61919-616 | Methocarbamol | Methocarbamol | DIRECT RX | ANDA | Current |
| 61919-616 | Methocarbamol | Methocarbamol | Direct_Rx | ANDA | Current |
| 61919-616 | Methocarbamol | Methocarbamol | Direct_Rx | ANDA | Current |
| 61919-616 | Methocarbamol | Methocarbamol | Direct_Rx | ANDA | Current |
| 61919-616 | Methocarbamol | Methocarbamol | DIRECT RX | ANDA | Current |
| 61919-616 | Methocarbamol | Methocarbamol | DIRECT RX | ANDA | Current |
| 61919-616 | Methocarbamol | Methocarbamol | DIRECT RX | ANDA | Current |
| 61919-616 | Methocarbamol | Methocarbamol | DIRECT RX | ANDA | Current |
| 61919-616 | Methocarbamol | Methocarbamol | DIRECT RX | ANDA | Current |
| 61919-616 | Methocarbamol | Methocarbamol | DIRECT RX | ANDA | Current |
| 61919-616 | Methocarbamol | Methocarbamol | DIRECT RX | ANDA | Current |
| 61919-616 | Methocarbamol | Methocarbamol | DIRECT RX | ANDA | Current |
| 62207-754 | Methocarbamol | Methocarbamol Tablets | Granules India Ltd | ANDA | Current |
| 62207-754 | Methocarbamol | Methocarbamol Tablets | Granules India Ltd | ANDA | Current |
| 62207-754 | Methocarbamol | Methocarbamol Tablets | Granules India Ltd | ANDA | Current |
| 62207-770 | Methocarbamol | Methocarbamol Tablets | Granules India Ltd | ANDA | Current |
| 62207-770 | Methocarbamol | Methocarbamol Tablets | Granules India Ltd | ANDA | Current |
| 62207-770 | Methocarbamol | Methocarbamol Tablets | Granules India Ltd | ANDA | Current |
| 63739-991 | Methocarbamol | Methocarbamol Tablets | McKesson Corporation dba SKY Packaging | ANDA | Current |
| 63739-992 | Methocarbamol | Methocarbamol Tablets | McKesson Corporation dba SKY Packaging | ANDA | Current |
| 67046-538 | Methocarbamol | Methocarbamol Tablets | Contract Pharmacy Services-PA | ANDA | Current |
| 68071-2867 | Methocarbamol | Methocarbamol Tablets | NuCare Pharmaceuticals,Inc. | ANDA | Current |
| 68071-4505 | Methocarbamol | Methocarbamol Tablets | NuCare Pharmaceuticals,Inc. | ANDA | Current |
| 68071-4505 | Methocarbamol | Methocarbamol Tablets | NuCare Pharmaceuticals,Inc. | ANDA | Current |
| 68071-4505 | Methocarbamol | Methocarbamol Tablets | NuCare Pharmaceuticals,Inc. | ANDA | Current |
| 68071-4505 | Methocarbamol | Methocarbamol Tablets | NuCare Pharmaceuticals,Inc. | ANDA | Current |
| 68071-4520 | Methocarbamol | Methocarbamol Tablets | NuCare Pharmaceuticals,Inc. | ANDA | Current |
| 68071-4520 | Methocarbamol | Methocarbamol Tablets | NuCare Pharmaceuticals,Inc. | ANDA | Current |
| 68788-8172 | Methocarbamol | Methocarbamol Tablets | Preferred Pharmaceuticals Inc. | ANDA | Current |
| 68788-8213 | Methocarbamol | Methocarbamol Tablets | Preferred Pharmaceuticals Inc. | ANDA | Current |
| 70010-754 | Methocarbamol | Methocarbamol Tablets | Granules Pharmaceuticals Inc. | ANDA | Current |
| 70010-754 | Methocarbamol | Methocarbamol Tablets | Granules Pharmaceuticals Inc. | ANDA | Current |
| 70010-754 | Methocarbamol | Methocarbamol Tablets | Granules Pharmaceuticals Inc. | ANDA | Current |
| 70010-770 | Methocarbamol | Methocarbamol Tablets | Granules Pharmaceuticals Inc. | ANDA | Current |
| 70010-770 | Methocarbamol | Methocarbamol Tablets | Granules Pharmaceuticals Inc. | ANDA | Current |
| 70010-770 | Methocarbamol | Methocarbamol Tablets | Granules Pharmaceuticals Inc. | ANDA | Current |
| 70518-1723 | Methocarbamol | Methocarbamol Tablets | REMEDYREPACK INC. | ANDA | Current |